Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis

INTRODUCTION: Several studies have indicated that early identification and treatment of patients with severe sepsis using standard supportive care improves outcomes. Earlier treatment with drotrecogin alfa (activated) (DrotAA) may also improve outcomes in severe sepsis. Using a recently constructed...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincent, Jean-Louis, O'Brien, James, Wheeler, Arthur, Wittebole, Xavier, Garg, Rekha, Trzaskoma, Benjamin L, Sundin, David P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550949/
https://www.ncbi.nlm.nih.gov/pubmed/16684364
http://dx.doi.org/10.1186/cc4909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550949/
https://www.ncbi.nlm.nih.gov/pubmed/16684364
http://dx.doi.org/10.1186/cc4909

Ejemplares similares